Skip to Main Content

Go to Main Navigation

Araclon Biotech

Year Established:
Company Type:
Large Business (>100M TTM Revenue)

Araclon Biotech is a small company founded in 2004 dedicated to the research and development of therapies and diagnostic methods for Alzheimer’s disease. Even though being a small company, Araclon is part of Grifols, being the major shareholder, so it has been classified as a large business.
Currently we offer the quantification of Alzheimer’s Disease relevant Aβ42 and Aβ40 peptides in plasma by two proprietary methods: ELISA and Liquid-Chromatography-Mass Spectrometry assays. These assays are carried out as a service at our facilities in Spain and US.

Site Badges
Araclon Biotech
Vía Hispanidad, 21 (edificio Araclon) Zaragoza, Zaragoza, 50009 Spain

Get started

To request access, simply fill out the form below and we will contact you.

Password must:

• Be at least 12 characters in length

• Contain a lowercase letter (a-z)

• Contain an uppercase letter (A-Z)

• Contain a numeral (0-9)

• Contain a special character (%, $, !, @)

By signing up for this account you agree to the Terms of Service